Barclays raised the firm’s price target on Intuitive Surgical to $510 from $490 and keeps an Overweight rating on the shares. The firm updated its model to reflect the company’s “strong” Q2 results and updated outlook.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Stock (NYSE:ISRG) Mid-Year Review: More Gains Are Likely
- Top Stock Gainers Today – MSTR, COIN, and More
- Early notable gainers among liquid option names on July 19th
- Intuitive Surgical price target raised to $475 from $460 at Morgan Stanley
- Intuitive Surgical price target raised to $520 from $515 at Truist